Cicaplast Baume B5+ for Rosacea with Sensitive Skin
CICAPLAST BAUME B5+
+ Standard cream
Supportive Care Study
Summary
Study start date: June 10, 2025
Actual date on which the first participant was enrolled.This study aims to evaluate the safety and effectiveness of a product called LA ROCHE-POSAY CICAPLAST BAUME B5+ for people with rosacea and sensitive skin. Rosacea is a common skin condition that causes redness and visible blood vessels on the face, which can be uncomfortable and affect self-esteem. Finding a safe and effective treatment for rosacea, especially for those with sensitive skin, is important because current options may not work for everyone or could cause irritation. By testing this product, the study hopes to provide a new option for people dealing with these skin concerns. Participants in the study will be divided into two groups. In the first phase, one group will apply the investigational product to their entire face twice a day, while the other group will use a placebo, which is a non-active version of the product, twice a day. Both groups will also use a standard sunscreen each morning. In the second phase, all participants will use the investigational product twice a day. Dermatologists will check the skin's condition at the start (Day 0) and then again on days 14, 28, and 56. Participants will also assess their own skin's condition at these times. Various tools will measure skin moisture, pH levels, and other factors, and a test for skin sensitivity will be done at the beginning and on Day 28. This thorough approach helps ensure the study gathers detailed information about how the product affects the skin.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.72 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Beijing Sino-German Union Cosmetic Institute Co., Ltd.
Beijing, ChinaOpen Beijing Sino-German Union Cosmetic Institute Co., Ltd. in Google Maps